NCT06835855

Brief Summary

The goal of this study is to examine attentional biases for facial displays of emotion as a mechanism of risk in infants of mothers with postpartum major depression, and the potential role of infant arousal in the development of these attentional biases.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
37mo left

Started Nov 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Nov 2024Jul 2029

Study Start

First participant enrolled

November 14, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2029

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

February 20, 2025

Status Verified

February 1, 2025

Enrollment Period

4.2 years

First QC Date

January 17, 2025

Last Update Submit

February 19, 2025

Conditions

Keywords

postpartuminfantattentionpsychophysiology

Outcome Measures

Primary Outcomes (4)

  • Eye gaze during computer-based task

    Used to determine percent of infant attention allocated to each emotional stimulus type (angry, happy, sad, neutral) during the computer-based task

    Baseline and 3-, 6-, 9-, and 12-month follow-up

  • Eye gaze during the interaction task

    Used to assess the proportion of time during each phase of the interaction task that babies look at their mother (versus away from their mother)

    Baseline and 3-, 6-, 9-, and 12-month follow-up

  • Infant Heart Rate

    During the interaction tasks, the investigators will record infant electrocardiography (ECG) to calculate heart rate (HR) using a MindWare Mobile system.

    Baseline and 3-, 6-, 9-, and 12-month follow-up

  • Infant Respiratory Sinus Arrhythmia

    During the interaction tasks, the investigators will record infant electrocardiography (ECG) to calculate respiratory sinus arrhythmia (RSA) using a MindWare Mobile system. To calculate RSA, spectral power analyses will be performed with a fast Fourier transformation. RSA will be defined as power density in the .24-1.04 Hz frequency band and will be calculated for each 30 s epoch of each task.

    Baseline and 3-, 6-, 9-, and 12-month follow ups

Secondary Outcomes (1)

  • Infant social-emotional problems

    Baseline and 3-, 6-, 9-, and 12-month follow-ups

Study Arms (1)

Experimental protocol for all infants

EXPERIMENTAL
Other: Passive Viewing TaskOther: Interaction Task

Interventions

Infants will complete a computer-based task in which they view facial displays of emotion (angry, happy, sad, neutral) while an eye tracker records their gaze.

Experimental protocol for all infants

Mother and infants will also complete a standardized interaction task during which we assess infant gaze and psychophysiology. The task consists of three stages, each of which lasts three minutes. For the first stage (Free Play 1), infants sit in a highchair and mothers are asked to play with their baby as they normally would, without any toys or other objects. In the second stage (Sad), mothers are asked to think about times when they are sad or depressed and do not feel able to effectively play with their child. They are instructed to look at their child but speak in a monotone and minimize body movement or any physical contact with the infant. In the third stage (Free Play 2), mothers again interact with their infants normally for three minutes.

Experimental protocol for all infants

Eligibility Criteria

Age6 Months+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The high-risk group (n = 150) will consist of women with at least one episode of MDD since their baby's birth.
  • To qualify for the low-risk group (n = 75), women cannot have a history of any depressive disorder or any current psychiatric diagnoses.
  • Infants will be required to be singleton children born full-term (\> 37 weeks) and normal weight (\> 2,500 grams) with no birth complications or health problems to avoid medical complications contributing to infants' attention, reactivity, and regulation measures.
  • The two groups will be matched on demographic factors (e.g., age, race/ethnicity, income).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Binghamton University

Binghamton, New York, 13902, United States

RECRUITING

Central Study Contacts

Brandon E Gibb, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2025

First Posted

February 19, 2025

Study Start

November 14, 2024

Primary Completion (Estimated)

February 1, 2029

Study Completion (Estimated)

July 1, 2029

Last Updated

February 20, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Individual participant data will be shared via the NIMH Data Archive (NDA). All data will be de-identified prior to submission to the repository, but the information needed to generate a global unique identifier for the NDA will be collected for each subject.

Time Frame
All data will be deposited to NDA starting 12 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates.
Access Criteria
Data will be findable for the research community through the NDA Collection that established when this application was funded. For all publications, an NDA study will be created. Each of those studies is assigned a digital object identifier (DOI). This data DOI will be referenced in the publication to allow the research community easy access to the exact data used in the publication.
More information

Locations